Forbes -
9 May 2014 22:00
Wall Street is optimistic about PDL BioPharma, which is slated to report its first quarter results on Monday, May 12, 2014. Analysts project a profit of 50 cents a share, a rise from 36 cents per share a year ago.The consensus estimate hasn't changed over the past month, but it's
Share this Article
Comment on this Article
Please to comment